Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SEH1L | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | ZNF184 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | NR2C2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | NUP160 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | PNRC2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | EXOSC2 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-07 |
mRNA | DDX39B | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | UBE3D | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | USP37 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | HNRNPA0 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |